.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Merck
Johnson and Johnson
Express Scripts
Moodys
Cerilliant
Healthtrust
Fuji
Julphar
Teva

Generated: July 22, 2017

DrugPatentWatch Database Preview

Dorzolamide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for dorzolamide hydrochloride and what is the scope of dorzolamide hydrochloride patent protection?

Dorzolamide hydrochloride
is the generic ingredient in five branded drugs marketed by Merck, Zach Systems, Bausch And Lomb, Hi Tech Pharma, Sandoz Inc, Watson Labs Inc, Teva Pharms, Luitpold, Apotex Inc, Sandoz, Akorn Inc, Oak Pharms Inc, and Lannett Holdings Inc, and is included in twenty-two NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for dorzolamide hydrochloride. Nine suppliers are listed for this compound.

Summary for Generic Name: dorzolamide hydrochloride

Tradenames:5
Patents:1
Applicants:13
NDAs:22
Drug Master File Entries: see list14
Suppliers / Packagers: see list9
Bulk Api Vendors: see list41
Clinical Trials: see list2,291
Patent Applications: see list422
Therapeutic Class:Ophthalmic Agents
Drug Prices:see low prices
DailyMed Link:dorzolamide hydrochloride at DailyMed

Pharmacology for Ingredient: dorzolamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
DORZOLAMIDE HYDROCHLORIDE
dorzolamide hydrochloride
SOLUTION/DROPS;OPHTHALMIC078981-001Apr 13, 2009ATRXNoNo► Subscribe► Subscribe
Lannett Holdings Inc
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
dorzolamide hydrochloride; timolol maleate
SOLUTION/DROPS;OPHTHALMIC201998-001Dec 17, 2014DISCNNoNo► Subscribe► Subscribe
Teva Pharms
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
dorzolamide hydrochloride; timolol maleate
SOLUTION/DROPS;OPHTHALMIC078704-001Sep 28, 2009ATRXNoNo► Subscribe► Subscribe
Oak Pharms Inc
COSOPT
dorzolamide hydrochloride; timolol maleate
SOLUTION/DROPS;OPHTHALMIC020869-001Apr 7, 1998ATRXYesYes► Subscribe► Subscribe
Bausch And Lomb
DORZOLAMIDE HYDROCHLORIDE
dorzolamide hydrochloride
SOLUTION/DROPS;OPHTHALMIC090143-001Jun 25, 2009ATRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: dorzolamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
TRUSOPT
dorzolamide hydrochloride
SOLUTION/DROPS;OPHTHALMIC020408-001Dec 9, 19944,619,939*PED► Subscribe
Merck
TRUSOPT
dorzolamide hydrochloride
SOLUTION/DROPS;OPHTHALMIC020408-001Dec 9, 19944,797,413*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Citi
Dow
Farmers Insurance
Queensland Health
Cantor Fitzgerald
US Department of Justice
Covington
Express Scripts
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot